EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Overcoming the challenges associated with identification of deep intronic variants by whole genome sequencing

Marie Dirix, Olivier Gribouval, Christelle Arrondel, Saadia Benjelloun, Olivia Boyer, Marina Charbit, Corinne Antignac, Laurence Heidet iD, Guillaume Dorval

Clinical Genetics · 2023-06 · 103 (6) · 693-698

DOI: 10.1111/cge.14305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 06.02.2023. Verfasst von Marie Dirix und 8 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1163, Laboratoire des Maladies Rénales Héréditaires, Institut Imagine, Université Paris-Cité, France. Hauptthemen laut MEDLINE: Nephrotic Syndrome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation pour la Recherche Médicale, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whole‐genome sequencing (WGS) now allows identification of multiple variants in non‐coding regions. The large number of variants identified by WGS however complicates their interpretation. Through identification of the first deep intronic variant in NPHS2 , which encodes podocin, a protein implicated in autosomal recessive steroid resistant nephrotic syndrome (SRNS), we compare herein three different tools including a newly developed targeted NGS‐based RNA‐sequencing to explore the splicing effect of intronic variations. WGS identified two different variants in NPHS2 eventually involved in the disease. Through RT‐PCR, exon‐trapping Minigene assay and targeted RNA sequencing, we were able to identify the splicing defect in NPHS2 mRNA from patient kidney tissue. Only targeted RNA‐seq simultaneously analyzed the effect of multiple variants and offered the opportunity to quantify consequences on splicing. Identifying deep intronic variants and their role in disease is of utmost importance. Alternative splicing can be predicted by in silico tools but always requires confirmation through functional testing with RNA analysis from the implicated tissue remaining the gold standard. When several variants with potential effects on splicing are identified by WGS, a targeted RNA sequencing panel could be of great value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrotic SyndromeHumansMutationWhole Genome SequencingRNA, Messenger

Stichwörter der Autor:innen

NPHS2RNAseqdeep intronic variantssplicing mutationsteroid resistant nephrotic syndromewhole-genome sequencing

Substanzen

RNA, Messenger

Autor:innen und Institutionen

  • INSERM U1163, Laboratoire des Maladies Rénales Héréditaires, Institut Imagine, Université Paris-Cité, France.
  • Laboratoires de biologie médicale SeqOIA, Paris, France.
  • Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte MARHEA, Hôpital Necker-Enfants Malades, Paris, France.
  • Service de Médecine Génomique des Maladies Rares, APHP, Université Paris-Cité, France.

ORCID-Profile: Laurence Heidet

Förderung

  • Fondation pour la Recherche Médicale
  • Agence Nationale de la Recherche

Zitieren

APA

Dirix, M., Gribouval, O., Arrondel, C., Benjelloun, S., Boyer, O., Charbit, M., Antignac, C., Heidet, L., & Dorval, G. (2023). Overcoming the challenges associated with identification of deep intronic variants by whole genome sequencing. Clinical Genetics, 103(6), 693-698. https://doi.org/10.1111/cge.14305

Vancouver

Dirix M, Gribouval O, Arrondel C, Benjelloun S, Boyer O, Charbit M, et al. Overcoming the challenges associated with identification of deep intronic variants by whole genome sequencing. Clinical Genetics. 2023;103(6):693-698. doi:10.1111/cge.14305

BibTeX
@article{Dirix2023,
  author = {Dirix, Marie and Gribouval, Olivier and Arrondel, Christelle and Benjelloun, Saadia and Boyer, Olivia and Charbit, Marina and Antignac, Corinne and Heidet, Laurence and Dorval, Guillaume},
  title = {Overcoming the challenges associated with identification of deep intronic variants by whole genome sequencing},
  journal = {Clinical Genetics},
  year = {2023},
  volume = {103},
  number = {6},
  pages = {693--698},
  doi = {10.1111/cge.14305}
}
Kostenlos starten →